Ansell Limited (ANSLF) 20.9000 $ANSLF
100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 1.37 (+0.06), GBSNU: 16.10 (-0.09), MZOR: 11.85 (+0.16), FEIC: 78.14 (+0.79), ZLTQ: 28.92 (+0.08), IART: 66.00 (+0.04), BVX: 2.70 (-0.07)
Top 100 Asia Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Apr 07, 4:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttv9s/asia_medical) has announced the addition of the "Asia Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical device companies remain bullish about Asian markets, driven by ageing populations, growing middle classes and government investments in healthcare. Strong demand for Asian medical devices has delivered sales growth of 44.1% compared to North/South America and Europe/Middle East/Africa. In 2012, the total value of the ASEAN medical device market was more than US $4 billion and the value is expected to increase to US $8 billion by 2017. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Asian companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical devices/technology/supplies companies - International presence of Asian medical devices/technology/supplies companies - R&D activities by Asian medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Asian Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Asian Medical Devices/Technology/Supplies Companies 3. Key News of Asian Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Asian Medical Devices/Technology/Supplies Companies 5. International Presence of Asian Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Asian Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Asian Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - Alfresa Pharma Corp (Japan) - Ansell Limited (Australia) - Arts Optical International Holdings Limited (Hong Kong) - AS ONE CORPORATION (Japan) - Asahi Intecc Co., Ltd. (Japan) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosensors International Group Ltd (Singapore) - Blue Sail Medical Co Ltd (China) - CHC Healthcare Group (Taiwan) - China Medical System Hldgs Ltd (Hong Kong) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Citadel Research And Solutions Private Limited (India) - Claris Lifesciences Ltd. (India) - Cochlear Limited (Australia) - Confident Dental Equipments Limited (India) - Da An Gene Co Ltd of Sun Yat-Sen University (China) - Dipped Products Plc (Sri Lanka) - Ebos Group Limited (New Zealand) - Enjoyor Co., Ltd. (China) For more information visit http://www.researchandmarkets.com/research/wt...ia_medical
Top 100 Global Medical Devices/Technology/Supplies Not Active in India 2015
M2 - Thu Apr 02, 8:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgm6pr/global_medical) has announced the addition of the "Global Medical Devices/Technology/Supplies Not Active in India 100" report to their offering. The global size of the medical devices sector is predicted to reach US $400 billion this year. However, India - a key player in the global pharmaceuticals industry, of which medical devices used to be covered - is underperforming. The country's market share stood at US $6.3 billion in 2013, contributing around 7-8 percent to overall healthcare spending in India as opposed to the 18 percent contributed by pharmaceuticals. With per capita spending estimated to be at less than US $3, it is understandable that the government feels FDI is the only way to spur domestic growth. Despite such figures, India's medical devices sector is expected to experience unprecedented growth during the next decade. By 2025, the industry is projected to be worth US $50 billion. This can be attributed to the country's growing middle class, an increase in the number of hospitals and, consequently, a greater need for sophisticated medical devices and better healthcare. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the global companies in the medical devices/technology/supplies industry, which they would find beneficial to pursue for making business decisions in this sector in India. Highlights: - Leading global 100 medical devices/technology/supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices/technology/supplies companies not active in India - International presence of global medical devices/technology/supplies companies not active in India - R&D activities by global medical devices/technology/supplies companies not active in India Key Topics Covered: 1: Rankings of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India News Section: 2: Key News of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India for Year 2014 3: Alliances among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 4: International Presence of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 5: Research and Development Activities by Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 6: Mergers and Acquisitions among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India Companies Mentioned: Partial List - Abaxis Inc (United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - American Science and Engineering, Inc. (United States) - Angiodynamics, Inc. (United States) - Ansell Limited (Australia) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Biosensors International Group Ltd (Singapore) - Cantel Medical Corp. (United States) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Cooper Companies Inc (United States) - Create Medic Co., Ltd. (Japan) - Cremer SA (Brazil) - Cryolife, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/dg...al_medical
ALGN: 59.28 (-0.03), ABAX: 52.74 (-0.01), ASEI: 39.97 (+0.01), CMN: 46.66 (-0.73), COO: 180.98 (+0.20)
Global Medical Supplies Not Active in India 100: 2015 Industry Report
M2 - Mon Mar 09, 5:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sw62st/global_medical) has announced the addition of the "Global Medical Supplies Not Active in India 100: An Industry Report" report to their offering. The medical supplies industry is essentially a growth industry. Affordability by patients, increased awareness on health care, improved hospital infrastructure, and the increased disease patterns are listed as the primary drivers boosting the growth of medical equipment and supplies industry. Free market environment, a developed industry, and investment in health infrastructure are amongst other factors that enhance the growth of high quality medical equipments and supplies industry. Disposable medical supplies are the largest segment within the global healthcare equipment and supplies sector. In recent times there is increased use of disposable medical supplies due to increasing incidence of diseases and disorders. Aging population and penalties for hospital acquired infection conditions are some of the key factors driving the growth for global disposable medical supplies market. In addition, increasing prevalence of incontinence problems is also fuelling the growth of global disposable medical supplies market. The Indian market for medical equipment and supplies ranks among the world's top 20 but, still, the market remains disproportionately small with very low per capita spending. However, China and India are expected to be the fastest growing disposable medical supplies markets in Asia region in the years to come. Some of the key driving forces for disposable medical supplies market in emerging countries are large pool of patients and improving healthcare services. Thus, the global medical technology companies which have not yet set a foot in the Indian medical supplies industry need to plan ahead to enter the Indian market. Report Highlights: - Leading global 100 medical supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical supplies companies not active in India - International presence of global medical supplies companies not active in India - R&D activities by global medical supplies companies not active in India Companies Mentioned (Partial List) - 3 D Matrix Ltd (Japan) - A&T Corporation (Japan) - ACS Global Inc (United States) - Acme United Corporation (United States) - Advanced Technology Company (Kuwait) - Adventa Berhad (Malaysia) - Agenix Limited (Australia) - Aigan Co., Ltd. (Japan) - Allegra Orthopaedics Ltd (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Antares Pharma, Inc. (United States) - Anteo Diagnostics Limited(Australia) - Apex Medical Corp. (Taiwan) - Aradigm Corporation (United States) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atricure, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/sw...al_medical
ACU: 17.44 (+0.39), ATRS: 2.08 (-0.09)
Disposable Medical Supplies Markets Report 2014 - Analysis of 14 Different Disposables & Profiles of 30+ Leading Manufacturers
M2 - Tue Feb 03, 5:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/bxn7p5/disposable) has announced the addition of the "Disposable Medical Supplies Markets Report 2014 - Analysis of 14 Different Disposables & Profiles of 30 Leading Manufacturers" report to their offering. Disposable Medical Supplies Markets Report 2014 has made a survey of selected companies marketing, manufacturing or developing various disposable medical supplies throughout the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included. Disposable medical supplies represent the largest segment within the global healthcare equipment and supplies sector. The global disposable medical supplies industry is primed to experience significant growth through the next decade, and this study provides in-depth analysis into the global and regional markets for these products. The purpose of this report is to give an insight into the specific market segment called disposable medical supplies. The disposable medical supplies include: - Conventional Syringes With Needles - Prefilled Syringes - Disposable Medical Catheters - Wound Care Products - Isolation Gowns - Surgical Drapes - Facemasks - Medical Gloves - Adult Incontinence Products - Blood Glucose Test Strips - Lancets - Lancing Devices - Procedure Kits And Trays - And Disposable Contact Lenses Key Topics Covered: 1. Introduction 2. Disposable Medical Supplies: An Overview 3. Medical Design Excellence Award Winning Disposable Medical Supplies, 2010-2011 4. Market Analysis: Medical Devices and Supplies 5. Market Analysis for Disposable Medical Supplies 6. Wound Care 7. Disposable Syringes and Needles 8. Catheters 9. Disposable Infusion Pumps 10. Custom Kits and Trays 11. Disposable Medical Gloves 12. Medical Non-wovens 13. Contact Lenses 14. Ostomy Care 15. Adult Incontinence 16. Global Market for Medical Device and Pharmaceutical Packaging 17. Global Market Value for Diabetes Test Strips 18. Company Profiles - Terumo Medical - Abbott - Rochester Medical Corporation - Medtronic - Merit Medical Systems, Inc. - St. Jude Medical, Inc. - Teleflex Medical - Smith & Nephew - Johnson & Johnson - Semperit Aktiengesellschaft Holding (SAG) - Alcon Laboratories, Inc. - C. R. Bard, Inc. - Cardinal Health, Inc. - Ansell Occupational Healthcare - DeRoyal Industries, Inc. - Ecolab - Covidien Ltd. - Kimberly-Clark - Medline Industries, Inc. - 3M HealthCare - Alpha Pro Tech Ltd. - Graham Medical - Dynarex Corp. - Ahlstrom Corp. - Ansell Ltd. - Baxter International, Inc. - BD Medical (Becton, Dickinson and Company) - Boston Scientific Corporation - Coloplast Ltd. - Top Glove Corporation Bhd For more information visit http://www.researchandmarkets.com/research/bxn7p5/disposable
MDT: 76.42 (+0.16), CAH: 87.55 (-0.45), COV: 106.71 (-1.36), BSX: 17.85 (-0.06), SNN: 35.29 (-0.06), JNJ: 102.30 (+0.47), APT: 2.36 (+0.01), BAX: 69.36 (+0.32), STJ: 74.96 (+0.47), MMSI: 20.64 (-0.10), ECL: 116.12 (+0.13)
Personal Protective Equipment Market - 2014-2020 Global Industry Analysis
M2 - Tue Jan 06, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/jslcjx/personal) has announced the addition of the "Personal Protective Equipment Market - Global Industry Analysis, Trend, Size, Share and Forecast 2014 - 2020" report to their offering. The personal protective equipment finds application across construction, manufacturing, oil and gas, pharmaceuticals, transportation and chemicals among others. The application of personal protective equipment in the manufacturing sector held the largest share. The manufacturing segment was valued at USD 6,714.1 million. The increasing awareness about workplace safety and government regulations are some of the major factors fuelling the demand for personal protective equipment in the manufacturing sector. However, the exponential growth in the logistics industry is boosting the demand for personal protective equipment in the transportation segment. The application of personal protective equipment in transportation sector is the fastest growing market. The transportation segment was valued at USD 2,604.6 million in 2013. Personal protective equipment includes head, eye and face protection, hearing protection, protective clothing, respiratory protection, professional footwear, fall protection, hand protection and others. Apart from this, personal protective equipment also finds application across various industries including construction, manufacturing, oil and gas, chemicals, food, pharmaceuticals, transportation and others. The others segment include government usage, unorganized sector, small-scale manufacturing utilities and service stations among others. Report Scope Personal Protective Equipment Market, by Application - Construction - Manufacturing - Oil and Gas - Chemicals - Food - Pharmaceuticals - Transportation - Others Personal Protective Equipment Market, by Type - Head, eye and face protection - Hearing protection - Protective clothing - Respiratory protection - Professional footwear - Fall protection - Hand protection - Others Companies Mentioned - 3M Co. - Alpha Pro Tech, Ltd. - Ansell Ltd. - Avon Rubber p.l.c. - COFRA Holding AG - Honeywell Safety Products - JAL Group - Oftenrich Holdings Company Limited (Golden Chang) - Rock Fall Ltd. - Uvex Safety Group For more information visit http://www.researchandmarkets.com/research/jslcjx/personal
MMM: 163.30 (+0.15), HON: 106.85 (+0.41), APT: 2.36 (+0.01)
Ansell Files Patent Infringement Lawsuit Against Reckitt Benckiser
PR Newswire - Wed Nov 19, 4:02PM CST
Ansell Ltd, a global leader in protection solutions, today announced that on 14 November 2014 the Company and Ansell Healthcare Products LLC (together "Ansell"
filed a patent infringement lawsuit against Reckitt Benckiser (Australia) Pty Limited ("Reckitt" and other related parties ("Respondents" . The action, filed in the New South Wales District Registry of the Federal Court of Australia, asserts that Reckitt has infringed Australian Patent No. 2009241426, titled "Dip-formed Synthetic Polyisoprene Latex Articles with Improved Intraparticle and Interparticle Crosslinks ("the Patent" ."
UTi Worldwide and Ansell Name Safmarine "Partner of the Year"
PRWeb - Wed Aug 20, 2:35AM CDT
UTi Worldwide Inc. (Nasdaq: UTIW), a global supply chain services and solutions company, together with its client, Ansell Limited, named Safmarine their "Partner of the Year" for 2013-2014 during their annual Ocean carrier performance review meeting in July.
UTIW: 9.61 (-0.09)
Global Condoms Strategic Business Report 2014: HIV/AIDS Prevention, A Strong Growth Driver
M2 - Thu Jul 17, 8:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vhxn7m/condoms_global) has announced the addition of the "Condoms - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Condoms in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 52 companies including many key and niche players such as: - Ansell Limited - Church & Dwight Co. Inc. - Fuji Latex Co. - HLL Lifecare Limited - Karex Industries Sdn Bhd Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Competition 3. Market Trends, Issues And Drivers 4. Product Profile 5. Recent Industry Activity 6. Product Innovations/Introductions 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 52 (including Divisions/Subsidiaries 56) - The United States (10) - Canada (1) - Japan (2) - Europe (16) - Germany (5) - The United Kingdom (6) - Italy (1) - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (24) - Latin America (1) - Africa (2) For more information visit http://www.researchandmarkets.com/research/vh...oms_global
CHD: 83.62 (+0.16)
Global Contraceptives Market 2014-2018 with Actavis, Bayer AG, J&J's, Janssen Pharma, Merck & Co., Pfizer, & Teva Pharmaceutical Leading the Way
M2 - Tue Jul 08, 10:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d964b9/global) has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering. The global contraceptives market is set to grow at a CAGR of 5.90 percent over the period 2013-2018. The Global Contraceptives market is driven by several factors, of which the growing prevalence of unplanned pregnancies is one of the major drivers. In order to control the 41 percent of unplanned pregnancies out of 208.2 million pregnancies globally, there has been an increase in the number of initiatives by governments and NGOs. Furthermore, the report states that one of the major challenges is the introduction of low-cost generic contraceptives. Recently, pharmaceutical companies have introduced new products into their portfolios or diversified their contraceptive drugs and devices. This trend has been primarily supported by several prominent deals or partnerships to develop or introduce new products with better efficacy and safety profiles. These strategic decisions will help companies to generate revenue and acquire a significant share of the Global Contraceptives market. Some of the major acquisitions in this space include Conceptus Inc. by Bayer, Warner Chilcott plc by Actavis, Uteron Pharma SA by Watson Pharmaceuticals Inc., and Barr Pharmaceuticals Inc. by Teva Pharmaceutical Industries. Some of the other prominent deals include Bayer and USAID partnering to make Microgynon, an oral contraceptive and Starpharma Holdings licensing agreement with Okamoto Industries Inc. for the VivaGel-coated condom. The global contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include: - Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives) - Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants) Key Vendors: - Actavis plc - Bayer AG - Johnson & Johnson's Janssen Pharmaceuticals, Inc. - Merck & Co. - Pfizer, Inc. - Teva Pharmaceutical Industries, Ltd Other Prominent Vendors: - Adamis Pharmaceuticals Corp. - Agile Therapeutics, Inc. - ANI Pharmaceuticals, Inc. - Ansell Ltd. - Apothecus Pharmaceutical Corp. - Blairex Laboratories Inc. - Church & Dwight, Co. Inc. - Caldwell Consumer Health, LLC. - Ferring International Center S.A - Fuji Latex Co., Ltd. - HLL Lifecare Limited - Mayer Laboratories - Medicines 360 - Karex Berhad - Lipocine Inc. - Lupin Pharmaceuticals, Inc. - Mylan Laboratories Inc. - Okamoto Industries, Inc. - Pantarhei Bioscience B.V. - Paul Hartmann AG - Reckitt Benckiser Group Plc - The Female Health Company For more information visit http://www.researchandmarkets.com/research/d964b9/global
CHD: 83.62 (+0.16), PFE: 33.99 (+0.05), ADMP: 4.28 (-0.12), MYL: 70.67 (-0.86), JNJ: 102.30 (+0.47), ANIP: 52.12 (+0.55), MRK: 60.23 (+0.45), LPCN: 7.66 (-0.04), TEVA: 60.23 (-0.99)
100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 1.37 (+0.06), GBSNU: 16.10 (-0.09), MZOR: 11.85 (+0.16), FEIC: 78.14 (+0.79), ZLTQ: 28.92 (+0.08), IART: 66.00 (+0.04), BVX: 2.70 (-0.07)
Top 100 Asia Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Apr 07, 4:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttv9s/asia_medical) has announced the addition of the "Asia Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical device companies remain bullish about Asian markets, driven by ageing populations, growing middle classes and government investments in healthcare. Strong demand for Asian medical devices has delivered sales growth of 44.1% compared to North/South America and Europe/Middle East/Africa. In 2012, the total value of the ASEAN medical device market was more than US $4 billion and the value is expected to increase to US $8 billion by 2017. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Asian companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical devices/technology/supplies companies - International presence of Asian medical devices/technology/supplies companies - R&D activities by Asian medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Asian Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Asian Medical Devices/Technology/Supplies Companies 3. Key News of Asian Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Asian Medical Devices/Technology/Supplies Companies 5. International Presence of Asian Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Asian Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Asian Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - Alfresa Pharma Corp (Japan) - Ansell Limited (Australia) - Arts Optical International Holdings Limited (Hong Kong) - AS ONE CORPORATION (Japan) - Asahi Intecc Co., Ltd. (Japan) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosensors International Group Ltd (Singapore) - Blue Sail Medical Co Ltd (China) - CHC Healthcare Group (Taiwan) - China Medical System Hldgs Ltd (Hong Kong) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Citadel Research And Solutions Private Limited (India) - Claris Lifesciences Ltd. (India) - Cochlear Limited (Australia) - Confident Dental Equipments Limited (India) - Da An Gene Co Ltd of Sun Yat-Sen University (China) - Dipped Products Plc (Sri Lanka) - Ebos Group Limited (New Zealand) - Enjoyor Co., Ltd. (China) For more information visit http://www.researchandmarkets.com/research/wt...ia_medical
Top 100 Global Medical Devices/Technology/Supplies Not Active in India 2015
M2 - Thu Apr 02, 8:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgm6pr/global_medical) has announced the addition of the "Global Medical Devices/Technology/Supplies Not Active in India 100" report to their offering. The global size of the medical devices sector is predicted to reach US $400 billion this year. However, India - a key player in the global pharmaceuticals industry, of which medical devices used to be covered - is underperforming. The country's market share stood at US $6.3 billion in 2013, contributing around 7-8 percent to overall healthcare spending in India as opposed to the 18 percent contributed by pharmaceuticals. With per capita spending estimated to be at less than US $3, it is understandable that the government feels FDI is the only way to spur domestic growth. Despite such figures, India's medical devices sector is expected to experience unprecedented growth during the next decade. By 2025, the industry is projected to be worth US $50 billion. This can be attributed to the country's growing middle class, an increase in the number of hospitals and, consequently, a greater need for sophisticated medical devices and better healthcare. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the global companies in the medical devices/technology/supplies industry, which they would find beneficial to pursue for making business decisions in this sector in India. Highlights: - Leading global 100 medical devices/technology/supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices/technology/supplies companies not active in India - International presence of global medical devices/technology/supplies companies not active in India - R&D activities by global medical devices/technology/supplies companies not active in India Key Topics Covered: 1: Rankings of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India News Section: 2: Key News of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India for Year 2014 3: Alliances among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 4: International Presence of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 5: Research and Development Activities by Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 6: Mergers and Acquisitions among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India Companies Mentioned: Partial List - Abaxis Inc (United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - American Science and Engineering, Inc. (United States) - Angiodynamics, Inc. (United States) - Ansell Limited (Australia) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Biosensors International Group Ltd (Singapore) - Cantel Medical Corp. (United States) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Cooper Companies Inc (United States) - Create Medic Co., Ltd. (Japan) - Cremer SA (Brazil) - Cryolife, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/dg...al_medical
ALGN: 59.28 (-0.03), ABAX: 52.74 (-0.01), ASEI: 39.97 (+0.01), CMN: 46.66 (-0.73), COO: 180.98 (+0.20)
Global Medical Supplies Not Active in India 100: 2015 Industry Report
M2 - Mon Mar 09, 5:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sw62st/global_medical) has announced the addition of the "Global Medical Supplies Not Active in India 100: An Industry Report" report to their offering. The medical supplies industry is essentially a growth industry. Affordability by patients, increased awareness on health care, improved hospital infrastructure, and the increased disease patterns are listed as the primary drivers boosting the growth of medical equipment and supplies industry. Free market environment, a developed industry, and investment in health infrastructure are amongst other factors that enhance the growth of high quality medical equipments and supplies industry. Disposable medical supplies are the largest segment within the global healthcare equipment and supplies sector. In recent times there is increased use of disposable medical supplies due to increasing incidence of diseases and disorders. Aging population and penalties for hospital acquired infection conditions are some of the key factors driving the growth for global disposable medical supplies market. In addition, increasing prevalence of incontinence problems is also fuelling the growth of global disposable medical supplies market. The Indian market for medical equipment and supplies ranks among the world's top 20 but, still, the market remains disproportionately small with very low per capita spending. However, China and India are expected to be the fastest growing disposable medical supplies markets in Asia region in the years to come. Some of the key driving forces for disposable medical supplies market in emerging countries are large pool of patients and improving healthcare services. Thus, the global medical technology companies which have not yet set a foot in the Indian medical supplies industry need to plan ahead to enter the Indian market. Report Highlights: - Leading global 100 medical supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical supplies companies not active in India - International presence of global medical supplies companies not active in India - R&D activities by global medical supplies companies not active in India Companies Mentioned (Partial List) - 3 D Matrix Ltd (Japan) - A&T Corporation (Japan) - ACS Global Inc (United States) - Acme United Corporation (United States) - Advanced Technology Company (Kuwait) - Adventa Berhad (Malaysia) - Agenix Limited (Australia) - Aigan Co., Ltd. (Japan) - Allegra Orthopaedics Ltd (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Antares Pharma, Inc. (United States) - Anteo Diagnostics Limited(Australia) - Apex Medical Corp. (Taiwan) - Aradigm Corporation (United States) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atricure, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/sw...al_medical
ACU: 17.44 (+0.39), ATRS: 2.08 (-0.09)
Disposable Medical Supplies Markets Report 2014 - Analysis of 14 Different Disposables & Profiles of 30+ Leading Manufacturers
M2 - Tue Feb 03, 5:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/bxn7p5/disposable) has announced the addition of the "Disposable Medical Supplies Markets Report 2014 - Analysis of 14 Different Disposables & Profiles of 30 Leading Manufacturers" report to their offering. Disposable Medical Supplies Markets Report 2014 has made a survey of selected companies marketing, manufacturing or developing various disposable medical supplies throughout the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included. Disposable medical supplies represent the largest segment within the global healthcare equipment and supplies sector. The global disposable medical supplies industry is primed to experience significant growth through the next decade, and this study provides in-depth analysis into the global and regional markets for these products. The purpose of this report is to give an insight into the specific market segment called disposable medical supplies. The disposable medical supplies include: - Conventional Syringes With Needles - Prefilled Syringes - Disposable Medical Catheters - Wound Care Products - Isolation Gowns - Surgical Drapes - Facemasks - Medical Gloves - Adult Incontinence Products - Blood Glucose Test Strips - Lancets - Lancing Devices - Procedure Kits And Trays - And Disposable Contact Lenses Key Topics Covered: 1. Introduction 2. Disposable Medical Supplies: An Overview 3. Medical Design Excellence Award Winning Disposable Medical Supplies, 2010-2011 4. Market Analysis: Medical Devices and Supplies 5. Market Analysis for Disposable Medical Supplies 6. Wound Care 7. Disposable Syringes and Needles 8. Catheters 9. Disposable Infusion Pumps 10. Custom Kits and Trays 11. Disposable Medical Gloves 12. Medical Non-wovens 13. Contact Lenses 14. Ostomy Care 15. Adult Incontinence 16. Global Market for Medical Device and Pharmaceutical Packaging 17. Global Market Value for Diabetes Test Strips 18. Company Profiles - Terumo Medical - Abbott - Rochester Medical Corporation - Medtronic - Merit Medical Systems, Inc. - St. Jude Medical, Inc. - Teleflex Medical - Smith & Nephew - Johnson & Johnson - Semperit Aktiengesellschaft Holding (SAG) - Alcon Laboratories, Inc. - C. R. Bard, Inc. - Cardinal Health, Inc. - Ansell Occupational Healthcare - DeRoyal Industries, Inc. - Ecolab - Covidien Ltd. - Kimberly-Clark - Medline Industries, Inc. - 3M HealthCare - Alpha Pro Tech Ltd. - Graham Medical - Dynarex Corp. - Ahlstrom Corp. - Ansell Ltd. - Baxter International, Inc. - BD Medical (Becton, Dickinson and Company) - Boston Scientific Corporation - Coloplast Ltd. - Top Glove Corporation Bhd For more information visit http://www.researchandmarkets.com/research/bxn7p5/disposable
MDT: 76.42 (+0.16), CAH: 87.55 (-0.45), COV: 106.71 (-1.36), BSX: 17.85 (-0.06), SNN: 35.29 (-0.06), JNJ: 102.30 (+0.47), APT: 2.36 (+0.01), BAX: 69.36 (+0.32), STJ: 74.96 (+0.47), MMSI: 20.64 (-0.10), ECL: 116.12 (+0.13)
Personal Protective Equipment Market - 2014-2020 Global Industry Analysis
M2 - Tue Jan 06, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/jslcjx/personal) has announced the addition of the "Personal Protective Equipment Market - Global Industry Analysis, Trend, Size, Share and Forecast 2014 - 2020" report to their offering. The personal protective equipment finds application across construction, manufacturing, oil and gas, pharmaceuticals, transportation and chemicals among others. The application of personal protective equipment in the manufacturing sector held the largest share. The manufacturing segment was valued at USD 6,714.1 million. The increasing awareness about workplace safety and government regulations are some of the major factors fuelling the demand for personal protective equipment in the manufacturing sector. However, the exponential growth in the logistics industry is boosting the demand for personal protective equipment in the transportation segment. The application of personal protective equipment in transportation sector is the fastest growing market. The transportation segment was valued at USD 2,604.6 million in 2013. Personal protective equipment includes head, eye and face protection, hearing protection, protective clothing, respiratory protection, professional footwear, fall protection, hand protection and others. Apart from this, personal protective equipment also finds application across various industries including construction, manufacturing, oil and gas, chemicals, food, pharmaceuticals, transportation and others. The others segment include government usage, unorganized sector, small-scale manufacturing utilities and service stations among others. Report Scope Personal Protective Equipment Market, by Application - Construction - Manufacturing - Oil and Gas - Chemicals - Food - Pharmaceuticals - Transportation - Others Personal Protective Equipment Market, by Type - Head, eye and face protection - Hearing protection - Protective clothing - Respiratory protection - Professional footwear - Fall protection - Hand protection - Others Companies Mentioned - 3M Co. - Alpha Pro Tech, Ltd. - Ansell Ltd. - Avon Rubber p.l.c. - COFRA Holding AG - Honeywell Safety Products - JAL Group - Oftenrich Holdings Company Limited (Golden Chang) - Rock Fall Ltd. - Uvex Safety Group For more information visit http://www.researchandmarkets.com/research/jslcjx/personal
MMM: 163.30 (+0.15), HON: 106.85 (+0.41), APT: 2.36 (+0.01)
Ansell Files Patent Infringement Lawsuit Against Reckitt Benckiser
PR Newswire - Wed Nov 19, 4:02PM CST
Ansell Ltd, a global leader in protection solutions, today announced that on 14 November 2014 the Company and Ansell Healthcare Products LLC (together "Ansell"
filed a patent infringement lawsuit against Reckitt Benckiser (Australia) Pty Limited ("Reckitt" and other related parties ("Respondents" . The action, filed in the New South Wales District Registry of the Federal Court of Australia, asserts that Reckitt has infringed Australian Patent No. 2009241426, titled "Dip-formed Synthetic Polyisoprene Latex Articles with Improved Intraparticle and Interparticle Crosslinks ("the Patent" ." UTi Worldwide and Ansell Name Safmarine "Partner of the Year"
PRWeb - Wed Aug 20, 2:35AM CDT
UTi Worldwide Inc. (Nasdaq: UTIW), a global supply chain services and solutions company, together with its client, Ansell Limited, named Safmarine their "Partner of the Year" for 2013-2014 during their annual Ocean carrier performance review meeting in July.
UTIW: 9.61 (-0.09)
Global Condoms Strategic Business Report 2014: HIV/AIDS Prevention, A Strong Growth Driver
M2 - Thu Jul 17, 8:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vhxn7m/condoms_global) has announced the addition of the "Condoms - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Condoms in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 52 companies including many key and niche players such as: - Ansell Limited - Church & Dwight Co. Inc. - Fuji Latex Co. - HLL Lifecare Limited - Karex Industries Sdn Bhd Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Competition 3. Market Trends, Issues And Drivers 4. Product Profile 5. Recent Industry Activity 6. Product Innovations/Introductions 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 52 (including Divisions/Subsidiaries 56) - The United States (10) - Canada (1) - Japan (2) - Europe (16) - Germany (5) - The United Kingdom (6) - Italy (1) - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (24) - Latin America (1) - Africa (2) For more information visit http://www.researchandmarkets.com/research/vh...oms_global
CHD: 83.62 (+0.16)
Global Contraceptives Market 2014-2018 with Actavis, Bayer AG, J&J's, Janssen Pharma, Merck & Co., Pfizer, & Teva Pharmaceutical Leading the Way
M2 - Tue Jul 08, 10:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d964b9/global) has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering. The global contraceptives market is set to grow at a CAGR of 5.90 percent over the period 2013-2018. The Global Contraceptives market is driven by several factors, of which the growing prevalence of unplanned pregnancies is one of the major drivers. In order to control the 41 percent of unplanned pregnancies out of 208.2 million pregnancies globally, there has been an increase in the number of initiatives by governments and NGOs. Furthermore, the report states that one of the major challenges is the introduction of low-cost generic contraceptives. Recently, pharmaceutical companies have introduced new products into their portfolios or diversified their contraceptive drugs and devices. This trend has been primarily supported by several prominent deals or partnerships to develop or introduce new products with better efficacy and safety profiles. These strategic decisions will help companies to generate revenue and acquire a significant share of the Global Contraceptives market. Some of the major acquisitions in this space include Conceptus Inc. by Bayer, Warner Chilcott plc by Actavis, Uteron Pharma SA by Watson Pharmaceuticals Inc., and Barr Pharmaceuticals Inc. by Teva Pharmaceutical Industries. Some of the other prominent deals include Bayer and USAID partnering to make Microgynon, an oral contraceptive and Starpharma Holdings licensing agreement with Okamoto Industries Inc. for the VivaGel-coated condom. The global contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include: - Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives) - Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants) Key Vendors: - Actavis plc - Bayer AG - Johnson & Johnson's Janssen Pharmaceuticals, Inc. - Merck & Co. - Pfizer, Inc. - Teva Pharmaceutical Industries, Ltd Other Prominent Vendors: - Adamis Pharmaceuticals Corp. - Agile Therapeutics, Inc. - ANI Pharmaceuticals, Inc. - Ansell Ltd. - Apothecus Pharmaceutical Corp. - Blairex Laboratories Inc. - Church & Dwight, Co. Inc. - Caldwell Consumer Health, LLC. - Ferring International Center S.A - Fuji Latex Co., Ltd. - HLL Lifecare Limited - Mayer Laboratories - Medicines 360 - Karex Berhad - Lipocine Inc. - Lupin Pharmaceuticals, Inc. - Mylan Laboratories Inc. - Okamoto Industries, Inc. - Pantarhei Bioscience B.V. - Paul Hartmann AG - Reckitt Benckiser Group Plc - The Female Health Company For more information visit http://www.researchandmarkets.com/research/d964b9/global
CHD: 83.62 (+0.16), PFE: 33.99 (+0.05), ADMP: 4.28 (-0.12), MYL: 70.67 (-0.86), JNJ: 102.30 (+0.47), ANIP: 52.12 (+0.55), MRK: 60.23 (+0.45), LPCN: 7.66 (-0.04), TEVA: 60.23 (-0.99)
